Prognostic significance of platelet-to-lymphocyte ratio (PLR) in patients with breast cancer treated with neoadjuvant chemotherapy: a meta-analysis

OBJECTIVE: Platelet-to-lymphocyte ratio (PLR), known as a key systemic inflammatory parameter, has been proved to be associated with response to neoadjuvant therapy in breast cancer (BC); however, the results remain controversial. This meta-analysis was carried out to evaluate the prognostic values...

Descripción completa

Detalles Bibliográficos
Autores principales: Qi, Xue, Chen, Jia, Wei, Sheng, Ni, Jingyi, Song, Li, Jin, Conghui, Yang, Lei, Zhang, Xunlei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10668253/
https://www.ncbi.nlm.nih.gov/pubmed/37996220
http://dx.doi.org/10.1136/bmjopen-2023-074874

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10668253/
https://www.ncbi.nlm.nih.gov/pubmed/37996220
http://dx.doi.org/10.1136/bmjopen-2023-074874

Ejemplares similares